189 related articles for article (PubMed ID: 2064632)
1. Familial aggregation of non-insulin dependent diabetes and coronary heart disease are accompanied by different effects on serum lipids, lipoproteins and apolipoproteins.
Sarlund H; Laakso M; Voutilainen E; Penttilä I; Pyörälä K
Atherosclerosis; 1991 Jan; 86(1):17-29. PubMed ID: 2064632
[TBL] [Abstract][Full Text] [Related]
2. Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients.
Rönnemaa T; Laakso M; Kallio V; Pyörälä K; Marniemi J; Puukka P
Am J Epidemiol; 1989 Oct; 130(4):632-45. PubMed ID: 2773912
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein profile in type II diabetic patients with and without coronary heart disease.
Barbagallo CM; Averna MR; Amato S; Marino G; Labisi M; Rao AC; Barbagallo M; Cupidi GF; Notarbartolo A
Acta Diabetol Lat; 1990; 27(4):371-7. PubMed ID: 2087939
[TBL] [Abstract][Full Text] [Related]
4. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Brunner D
Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618
[TBL] [Abstract][Full Text] [Related]
5. Early abnormalities in coronary heart disease risk factors in relatives of subjects with non-insulin-dependent diabetes.
Sarlund H; Pyörälä K; Penttilä I; Laakso M
Arterioscler Thromb; 1992 Jun; 12(6):657-63. PubMed ID: 1591229
[TBL] [Abstract][Full Text] [Related]
6. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
[TBL] [Abstract][Full Text] [Related]
7. Serum sialic acid concentration and coronary heart disease in NIDDM.
Pickup JC; Mattock MB; Crook MA; Chusney GD; Burt D; Fitzgerald AP
Diabetes Care; 1995 Aug; 18(8):1100-3. PubMed ID: 7587844
[TBL] [Abstract][Full Text] [Related]
8. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.
O'Neal DN; Lewicki J; Ansari MZ; Matthews PG; Best JD
Atherosclerosis; 1998 Jan; 136(1):1-8. PubMed ID: 9544725
[TBL] [Abstract][Full Text] [Related]
9. Lipoproteins and apolipoproteins in young nonobese Arab women with NIDDM treated with insulin.
Al-Muhtaseb N; Al-Yusuf AR; Abdella N; Fenech F
Diabetes Care; 1989 May; 12(5):325-31. PubMed ID: 2656141
[TBL] [Abstract][Full Text] [Related]
10. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
Diabetes Care; 2000 Jun; 23(6):791-5. PubMed ID: 10840998
[TBL] [Abstract][Full Text] [Related]
11. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.
Siegel RD; Cupples A; Schaefer EJ; Wilson PW
Metabolism; 1996 Oct; 45(10):1267-72. PubMed ID: 8843183
[TBL] [Abstract][Full Text] [Related]
12. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.
Laakso M; Lehto S; Penttilä I; Pyörälä K
Circulation; 1993 Oct; 88(4 Pt 1):1421-30. PubMed ID: 8403288
[TBL] [Abstract][Full Text] [Related]
13. Association of coronary heart disease with serum lipid and apolipoprotein concentrations in long-term diabetes. Results of the Erfurt study.
Schauer UJ; Pissarek D; Panzram G
Acta Diabetol Lat; 1989; 26(1):35-42. PubMed ID: 2501960
[TBL] [Abstract][Full Text] [Related]
14. The contribution of lipids to coronary heart disease in diabetes mellitus.
Stewart MW; Laker MF; Alberti KG
J Intern Med Suppl; 1994; 736():41-6. PubMed ID: 7986307
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women.
al-Muhtaseb N; al-Yusef AR; Bajaj JS
Diabet Med; 1991 Oct; 8(8):732-7. PubMed ID: 1838064
[TBL] [Abstract][Full Text] [Related]
16. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244
[TBL] [Abstract][Full Text] [Related]
17. Changes in glucose, insulin, lipid, lipoprotein, and apoprotein concentrations and insulin action in doxazosin-treated patients with hypertension. Comparison between nondiabetic individuals and patients with non-insulin-dependent diabetes mellitus.
Maheux P; Facchini F; Jeppesen J; Greenfield MS; Clinkingbeard C; Chen YD; Reaven GM
Am J Hypertens; 1994 May; 7(5):416-24. PubMed ID: 8060574
[TBL] [Abstract][Full Text] [Related]
18. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
[TBL] [Abstract][Full Text] [Related]
19. Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations.
Deng K; Pan XF; Voehler MW; Cai Q; Cai H; Shu XO; Gupta DK; Lipworth L; Zheng W; Yu D
J Am Heart Assoc; 2024 May; 13(10):e034364. PubMed ID: 38726919
[TBL] [Abstract][Full Text] [Related]
20. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.
Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W;
Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
